Kalypsys Patents – Insights & Stats (Updated 2023)

Kalypsys has a total of 342 patents globally, out of which 63 have been granted. Of these 342 patents, more than 14% patents are active. The USA is where Kalypsys has filed the maximum number of patents, followed by Europe (EPO). Parallelly, the USA seems to be the main focused R&D center of Kalypsys and is also the origin country of the firm. Kalypsys was founded in the year 2001 by Kevin Lustig, Peter Schultz, Pratik Shah and Randall King. Company operates as a pharmaceutical company. The Company offers treatment for cardiovascular, metabolic, pain, inflammation, and oncology diseases. Do read about some of the most popular patents of Kalypsys which have been covered by us in this article and also you can find Kalypsys patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Kalypsys patent portfolio.

How many patents does Kalypsys have?

Kalypsys has a total of 342 patents globally. These patents belong to 88 unique patent families. Out of 342 patents, 49 patents are active.

How Many Patents did Kalypsys File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant Kalypsys Applications Filed Kalypsys Patents Granted
2022
2021 1
2020
2019
2018 8
2017 1
2016 4
2015 4
2014 8
2013 3 6
2012 13 8
2011 32 7
 

How many Kalypsys patents are Alive/Dead?

Worldwide Patents

How Many Patents did Kalypsys File in Different Countries?

Countries in which Kalypsys Filed Patents
Country Patents
United States Of America 66
Europe 19
Canada 17
Taiwan 17
Argentina 15
Australia 14
Japan 14
China 13
Korea (South) 13
India 12
Mexico 11
Brazil 10
Israel 6
Uruguay 6
South Africa 5
Germany 4
Austria 4
Spain 4
Hong Kong (S.A.R.) 4
Philippines 3
New Zealand 3
Denmark 2
Hungary 2
Russia 1
Colombia 1
Singapore 1
Chile 1
Indonesia 1

Where are Research Centres of Kalypsys Patents Located?

10 Best Kalypsys Patents

US20080021026A1 is the most popular patent in the Kalypsys portfolio. It has received 175 citations so far from companies like Aerie Pharmaceuticals. Below is the list of 10 most cited patents of Kalypsys: 
Publication Number Citation Count
US20080021026A1 175
WO2004092117A1 125
US20100063047A1 113
US20080021217A1 108
WO2008097976A1 101
WO2008157500A1 94
US20080221161A1 93
US20050234046A1 76
WO2009029625A1 76
WO2009029617A1 70

What are Kalypsys key innovation segments?

What Technologies are Covered by Kalypsys?

The chart below distributes patents filed by Kalypsys in different countries on the basis of the technology protected in patents. It also represents the markets where Kalypsys thinks it’s important to protect particular technology inventions.

R&D Focus: How has Kalypsys search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Kalypsys?

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.